Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Steve's Channelling Thread -- Ignore unavailable to you. Want to Upgrade?

To: captaintime who wrote (22756)	8/2/2001 6:32:15 PM
From: Sully-	Read Replies (1) \| Respond to of 30051

Protein Design (PDLI) 54.41 -0.55: -- Clarification-- In earlier post, Briefing.com indicated that PDLI warned for the full year... although the company's current expectation for breakeven results is below the current First Call consensus of $0.06, that guidance is actually unchanged from the guidance PDLI provided on May 14... investors appear disappointed nonetheless that PDLI was unable to raise guidance to meet analysts' higher expectations. Protein Design (PDLI) 54.41 -0.55: -- Update -- Company warns for full year 2001; sees results of break even vs current consensus EPS estimate of $0.06. Protein Design (PDLI) 54.41 -0.55: Reports Q2 earnings of $0.07 a share, $0.01 better than the First Call consensus of $0.06, vs year-ago earnings of $0.12; revenues rose 6.3% to $21.65 mln from a year-ago of $20.36 mln; "guidance is unchanged from that provided in PDL's last financial press release issued May 14, 2001."